Crohn Disease Clinical Trials in Miami, Florida

6 studies are recruiting for crohn disease in Miami, Florida right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

  1. A Master Protocol (IIBD): A Study of Multiple Drugs in Adults With Ulcerative Colitis or Crohn's Disease

    Study IIBD is a master protocol that will support a collection of individual sub studies that share key design components. Participants will be assigned to the appropriate study prior to randomization to a treatment group. The studies aim to evaluate the efficacy and safety of new treatments in adu…

    Stage
    Phase 2
    Ages
    18 to 80
    Site
    Gastro Health Research - Miami, Miami, Florida
    Locations
    70 in total
    Run by
    Eli Lilly and Company

    See if you can join NCT07483073 on ClinicalTrials.gov

  2. A Study of LY4395089 and Mirikizumab (LY3074828) Given Together and Mirikizumab (Alone) in Adults With Crohn's Disease

    The main purpose of this study is to see how the safety and efficacy of a farnesoid X receptor (FXR) agonist (LY4395089), given together with mirikizumab compares with mirikizumab (alone) in adults with moderately to severely active Crohn's disease (CD). This study is part of the IIBD master protoc…

    Stage
    Phase 2
    Ages
    18 to 80
    Site
    Gastro Health Research - Miami, Miami, Florida
    Locations
    70 in total
    Run by
    Eli Lilly and Company

    See if you can join NCT07483099 on ClinicalTrials.gov

  3. A Study of Icotrokinra in Participants With Moderately to Severely Active Crohn's Disease

    The purpose of this study is to evaluate how-well icotrokinra works (clinical efficacy) and how safe it is (safety) in participants with moderately to severely active Crohn's disease (CD; a long-term condition causing severe inflammation of the intestinal tract).

    Stage
    Phase 2
    Ages
    18 and older
    Site
    Sanchez Clinical Research, Inc, Miami, Florida
    Locations
    370 in total
    Run by
    Janssen Research & Development, LLC

    See if you can join NCT07196722 on ClinicalTrials.gov

  4. A Study of Guselkumab Versus Risankizumab in Participants With Moderately to Severely Active Crohn's Disease

    The purpose of this study is to assess how well guselkumab works when compared to risankizumab in participants with moderately to severely active Crohn's Disease (CD; a long-term condition causing severe inflammation of the intestinal tract).

    Stage
    Phase 3
    Ages
    18 and older
    Site
    Sanchez Clinical Research, Inc, Miami, Florida
    Locations
    160 in total
    Run by
    Janssen Research & Development, LLC

    See if you can join NCT07499232 on ClinicalTrials.gov

  5. A Study of JNJ-78934804 in Participants With Moderately to Severely Active Crohn's Disease

    The purpose of this study is to assess how well JNJ-78934804 works (efficacy) and how safe it is (safety) as compared to guselkumab at Week 48 in participants with moderately to severely active Crohn's disease (a long-term, progressive [worsens with time] and life-threatening disease of the intesti…

    Stage
    Phase 3
    Ages
    18 and older
    Site
    Sanchez Clinical Research, Inc, Miami, Florida
    Locations
    142 in total
    Run by
    Janssen Research & Development, LLC

    See if you can join NCT07577843 on ClinicalTrials.gov

  6. Glucagon-like Peptide-1 Receptor Agonist (GLP-1 RA) and Diet in Inflammatory Bowel Disease (IBD) Patients

    The purpose of this study is to use diet and an injectable medication called tirzepatide (Zepbound) glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1 receptor agonist (GIP-GLP-1 RA) medication as adjunctive therapy (another treatment used together with the primary treatment) …

    Stage
    Phase 4
    Ages
    18 and older
    Site
    University of Miami, Miami, Florida
    Run by
    University of Miami

    See if you can join NCT06774079 on ClinicalTrials.gov

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.